Risk of thromboembolism with thrombopoietin receptor agonists in adult patients with thrombocytopenia: Systematic review and meta-analysis of randomized controlled trials
- 1 December 2015
- journal article
- review article
- Published by Elsevier BV in Medicina Clinica
- Vol. 145 (12), 511-519
- https://doi.org/10.1016/j.medcli.2015.03.014
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Metaanálisis de ensayos clínicos aleatorizados, heterogeneidad e intervalos de predicciónMedicina Clinica, 2014
- A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomideJournal of Hematology & Oncology, 2012
- A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopeniaJournal of Thrombosis and Haemostasis, 2012
- Romiplostim or Standard of Care in Patients with Immune ThrombocytopeniaThe New England Journal of Medicine, 2010
- Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisisMedicina Clinica, 2010
- Thrombopoietic agentsBlood Reviews, 2010
- Measuring inconsistency in meta-analysesBMJ, 2003
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986